Blockchain Registration Transaction Record

Kessler Topaz Meltzer & Check, LLP Files Securities Class Action Lawsuit Against Cassava Sciences, Inc.

Kessler Topaz Meltzer & Check, LLP has filed a securities class action lawsuit against Cassava Sciences, Inc. on behalf of investors who purchased Cassava securities. The lawsuit alleges false statements about the effectiveness of Cassava's drug in treating Alzheimer's Disease. Investors affected by potential misconduct have until February 10, 2025, to seek appointment as lead plaintiff representatives.

This news highlights the importance of transparency and accuracy in pharmaceutical companies' communications about their products. Investors who may have been misled by false statements regarding the effectiveness of Cassava's drug now have the opportunity to seek recourse through legal action.